Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates
Regeneron Pharmaceuticals has signed a $2.32bn research collaboration with Parabilis Medicines to develop therapeutic candidates leveraging the latter’s Helicon peptide…
All articles by Salong Debbarma
Salong Debbarma
-
-
Japan’s MHLW approves Boehringer’s Jascayd for IPF and PPF
Boehringer Ingelheim has received Japan’s Ministry of Health, Labour and Welfare (MHLW) approval for Jascayd (nerandomilast) to treat adults with…
-
FDA approves Enhertu for two HER2-positive early breast cancer indications
The US Food and Drug Administration (FDA) has approved Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) for two new indications…
-
Arna Pharma and Slate Run complete JV for new US company
Arna Pharma and Slate Run Pharmaceuticals have completed a joint venture (JV) to form a speciality pharmaceutical company in the…
-
Kyowa Kirin secures FDA approval for Crysvita dosing update
Kyowa Kirin has received approval from the US Food and Drug Administration (FDA) for a dosing update to the prescribing…
-
Zydus to acquire Assertio in $166m deal
Zydus Lifesciences (Zydus) is set to acquire all outstanding Assertio common shares in a deal valued at around $166.4m, through…
-
Coya Therapeutics secures FDA fast track status for COYA 302
Coya Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for COYA 302, an investigational…
-
Pfizer receives EC approval for Hympavzi to treat haemophilia
Pfizer has received the European Commission’s (EC) marketing authorisation for expanding the approved Hympavzi (marstacimab) indication to treat haemophilia A or…
-
UAE approves AstraZeneca’s Baxfendy for hypertension
AstraZeneca has received approval from the Emirates Drug Establishment (EDE) in the United Arab Emirates (UAE) for Baxfendy, a medicine…
-
Isomorphic Labs receives $2.1bn for AI drug development
AI drug design and development company Isomorphic Labs has secured $2.1bn in Series B funding to expedite its transition from…